Significance of PIK3CA mutations in patients with early breast cancer treated with adjuvant chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) study

被引：0
|
作者：
Papaxoinis, G. [1 ]
Kotoula, V. [1 ]
Alexopoulou, Z. [2 ]
Charalambous, E. [1 ]
Zagouri, F. [1 ]
Timotheadou, E. [1 ]
Gogas, H. [1 ]
Pentheroudakis, G. [1 ]
Koutras, A. [1 ]
Christodoulou, C. [1 ]
Bafaloukos, D. [1 ]
Aravantinos, G. [1 ]
Kalogeras, K. T. [1 ]
Pectasides, D. [1 ]
Fountzilas, G. [1 ]
机构：
[1] Hellen Cooperat Oncol Grp, Data Off, Athens, Greece
[2] Hlth Data Specialists Ltd, Biostat, Athens, Greece
来源：
EUROPEAN JOURNAL OF CANCER | 2015年 / 51卷
关键词：
D O I：
10.1016/S0959-8049(16)30924-8
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1976
引用
收藏
页码：S325 / S326
页数：2
相关论文
共 50 条
  • [1] Significance of PIK3CA Mutations in Patients with Early Breast Cancer Treated with Adjuvant Chemotherapy: A Hellenic Cooperative Oncology Group (HeCOG) Study
    Papaxoinis, George
    Kotoula, Vassiliki
    Alexopoulou, Zoi
    Kalogeras, Konstantine T.
    Zagouri, Flora
    Timotheadou, Eleni
    Gogas, Helen
    Pentheroudakis, George
    Christodoulou, Christos
    Koutras, Angelos
    Bafaloukos, Dimitrios
    Aravantinos, Gerasimos
    Papakostas, Pavlos
    Charalambous, Elpida
    Papadopoulou, Kyriaki
    Varthalitis, Ioannis
    Efstratiou, Ioannis
    Zaramboukas, Thomas
    Patsea, Helen
    Scopa, Chrisoula D.
    Skondra, Maria
    Kosmidis, Paris
    Pectasides, Dimitrios
    Fountzilas, George
    PLOS ONE, 2015, 10 (10):
  • [2] Adjuvant aromatase inhibitors in patients with PIK3CA mutation early breast cancer
    Reinhardt, K.
    Vetter, M.
    Kaufhold, S.
    Kantelhardt, E.
    Thomssen, C.
    ANNALS OF ONCOLOGY, 2023, 34 : S296 - S296
  • [3] Prognosis of women with early breast cancer and PIK3CA mutations
    Di Cosimo, Serena
    Bianchi, Giulia Valeria
    Bregni, Giacomo
    de Braud, Filippo
    BREAST, 2015, 24 (03): : 283 - 284
  • [4] Expression of angiogenic markers in the peripheral blood of docetaxel-treated advanced breast cancer patients: A Hellenic Cooperative Oncology Group (HeCOG) study
    Pectasides, Dimitrios
    Papaxoinis, George
    Kotoula, Vassiliki
    Fountzilas, Helen
    Korantzis, Ippokratis
    Koutras, Angelos
    Dimopoulos, Athanasios M.
    Papakostas, Pavlos
    Aravantinos, Gerasimos
    Varthalitis, Ioannis
    Kosmidis, Paris
    Skarlos, Dimosthenis
    Bournakis, Evangelos
    Bafaloukos, Dimitrios
    Kalofonos, Haralabos P.
    Kalogeras, Konstantine T.
    Fountzilas, George
    ONCOLOGY REPORTS, 2012, 27 (01) : 216 - 224
  • [5] Adjuvant chemotherapy with paclitaxel and carboplatin in patients with advanced bladder cancer: A study by the Hellenic Cooperative Oncology Group
    Bamias, A
    Deliveliotis, C
    Aravantinos, G
    Kalofonos, C
    Karayiannis, A
    Dimopoulos, MA
    JOURNAL OF UROLOGY, 2004, 171 (04): : 1467 - 1470
  • [6] Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study
    Angelos Koutras
    Konstantine T Kalogeras
    Ralph M Wirtz
    Zoi Alexopoulou
    Mattheos Bobos
    Flora Zagouri
    Elke Veltrup
    Eleni Timotheadou
    Helen Gogas
    George Pentheroudakis
    Nikolaos Pisanidis
    Christina Magkou
    Christos Christodoulou
    Dimitrios Bafaloukos
    Pavlos Papakostas
    Gerasimos Aravantinos
    Dimitrios Pectasides
    Haralambos P Kalofonos
    George Fountzilas
    Journal of Translational Medicine, 13
  • [7] Adjuvant dose-dense sequential chemotherapy with epirubicin, CMF and weekly paclitaxel in patients with resected high-risk breast cancer: A Hellenic Cooperative Oncology Group (HeCOG) study
    Papadimitriou, Christos A.
    Papakostas, Pavlos
    Timotheadou, Eleni
    Aravantinos, Gerasimos
    Bamias, Aristotelis
    Fountzilas, George
    CANCER INVESTIGATION, 2008, 26 (05) : 491 - 498
  • [8] EXPRESSION OF ANGIOGENIC MARKERS IN THE PERIPHERAL BLOOD OF DOCETAXEL-TREATED ADVANCED BREAST CANCER PATIENTS. A HELLENIC COOPERATIVE ONCOLOGY GROUP (HECOG) STUDY
    Dimoudis, S.
    Korantzis, I.
    Papaxoinis, G.
    Fountzilas, E.
    Koutras, A. K.
    Res, E.
    Skarlos, D.
    Bournakis, E.
    Bafaloukos, D.
    Fountzilas, G.
    ANNALS OF ONCOLOGY, 2011, 22 : 62 - 62
  • [9] Evaluation of the prognostic significance of HER family mRNA expression in high-risk early breast cancer: a Hellenic Cooperative Oncology Group (HeCOG) validation study
    Koutras, Angelos
    Kalogeras, Konstantine T.
    Wirtz, Ralph M.
    Alexopoulou, Zoi
    Bobos, Mattheos
    Zagouri, Flora
    Veltrup, Elke
    Timotheadou, Eleni
    Gogas, Helen
    Pentheroudakis, George
    Pisanidis, Nikolaos
    Magkou, Christina
    Christodoulou, Christos
    Bafaloukos, Dimitrios
    Papakostas, Pavlos
    Aravantinos, Gerasimos
    Pectasides, Dimitrios
    Kalofonos, Haralambos P.
    Fountzilas, George
    JOURNAL OF TRANSLATIONAL MEDICINE, 2015, 13
  • [10] INVESTIGATION OF THYMIDYLATE SYNTHASE (TS) AND TOPOISOMERASE-1 EXPRESSION IN PATIENTS WITH RESECTED COLORECTAL CANCER (RCRC) TREATED WITH ADJUVANT CHEMOTHERAPY. A RETROSPECTIVE STUDY OF THE HELLENIC COOPERATIVE ONCOLOGY GROUP (HECOG)
    Kostopoulos, I.
    Karavasilis, V.
    Karina, M.
    Bobos, M.
    Xiros, N.
    Petraki, C.
    Pentheroudak, G.
    Kafiri, G.
    Papakostas, P.
    Fountzilas, G.
    ANTICANCER RESEARCH, 2008, 28 (5C) : 3342 - 3342
12345